(Q35181821)
Statements
1 reference
11 references
13 March 2019
14 March 2019
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials (English)
1 reference
7 references
13 March 2019
14 March 2019
Odd Erik Johansen
1 reference
Bernard Zinman
1 reference
Silvio E Inzucchi
1 reference
Christoph Wanner
1 reference
Roberto Ferrari
1 reference
David Fitchett
1 reference
Stefan Hantel
1 reference
Rosa-Maria Espadero
1 reference
Hans-Jürgen Woerle
1 reference
Uli C Broedl
1 reference
14 January 2015
1 reference
1 March 2015
11 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
9 October 2019
18 November 2019
30 January 2021
4 February 2021
19 July 2022
24 August 2022
12 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
9 October 2019
18 November 2019
30 January 2021
4 February 2021
19 July 2022
24 August 2022
12
1 reference
2
1 reference
90-100
1 reference
11 references
13 March 2019
14 March 2019
24 March 2019
17 June 2019
2 October 2019
9 October 2019
18 November 2019
30 January 2021
4 February 2021
19 July 2022
24 August 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference